Unlock: Penumbra (PEN) Power Breakout after Unusual Call Flow

(At JaguarAnalytics, every single piece of research note and trade idea is packaged with three critical ingredients: fundamentals, technicals and option activity. It is the foundation of our vetting process before a discussion is presented to clients. Below is one of many examples, issued on May 23. An excerpt from detailed discussion. Stock surged higher today with a power candle, up +14% since this note.)

To learn more about our approach and how you can become a successful trader, sign up for 2 week trial and test drive live chat room with some of the best traders: SUBSCRIBE

Penumbra (PEN) – The type of price action that nobody would care for but gets my attention. IPO happened in October 2015 so fairly new. With stock currently at $51.70 unusual and aggressive buyer of 250 October 60 calls pays $2.75 offer side on wide bid/ask spread of 1.10 x 2.75. Approx $68,750 bullish bet. Also seeing small call buying in July 55.

Penumbra is $1.6 billion MedTech that addresses needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. Posted monster revenue growth in last two quarters and raised guidance each time ….